Fate Therapeutics (FATE) Receivables (2015 - 2026)
Fate Therapeutics (FATE) reported Receivables of $704000.0 for Q1 2026, down 70.74% on a YoY basis from $2.4 million in Q1 2025, and down 23.14% quarter-over-quarter from $916000.0 in Q4 2025.
Fate Therapeutics (FATE) Receivables (2015 - 2026) Analysis & Trends
Fate Therapeutics has reported Receivables for 10 years, with the latest figure at $704000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables fell 70.74% year-over-year to $704000.0; the trailing twelve-month figure through Mar 2026 stood at $704000.0 (down 70.74% YoY), and the FY2025 full-year result was $916000.0, down 74.12% from the prior year.
- Receivables for Q1 2026 stood at $704000.0, down from $916000.0 in the prior quarter.
- The five-year high for Receivables was $38.5 million in Q4 2022, with the low at $682000.0 in Q3 2025.
- Historically, Receivables has averaged $6.5 million across 5 years, with a median of $2.4 million in 2025.
- Annual changes were most pronounced in 2022 — Receivables soared 343.52% — and 2023, when it plunged 95.25%.
- Fate Therapeutics' Receivables stood at $38.5 million in 2022, then sank by 95.25% to $1.8 million in 2023, then surged by 93.81% to $3.5 million in 2024, then slumped by 74.12% to $916000.0 in 2025, then fell by 23.14% to $704000.0 in 2026.
- The last three Receivables figures came in at $704000.0 (Q1 2026), $916000.0 (Q4 2025), and $682000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | 704,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 704,000.00 |
| Dec 31, 2025 | 916,000.00 |
| Sep 30, 2025 | 682,000.00 |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 858,000.00 |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 13.50 Mn |
| Dec 31, 2022 | 38.48 Mn |
| Sep 30, 2022 | 10.22 Mn |
| Jun 30, 2022 | 13.13 Mn |
| Mar 31, 2022 | 13.85 Mn |
| Dec 31, 2021 | 8.68 Mn |
| Sep 30, 2021 | 7.31 Mn |
| Jun 30, 2021 | 10.30 Mn |